BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 1699682)

  • 1. Acute and subacute toxicity of chemotactic conjugates between monoclonal antibody and fMet-Leu-Phe in humans: a phase I clinical trial.
    Obrist R; Schmidli J; Müller R; Gallati H; Obrecht JP
    Cancer Immunol Immunother; 1991; 32(6):406-8. PubMed ID: 2007248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Robust Bioassay of the Human Bradykinin B
    Marceau F; Bachelard H
    Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33668382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67.
    Alshammari AM; Smith DD; Parriott J; Stewart JP; Curran SM; McCulloh RJ; Barry PA; Iyer SS; Palermo N; Phillips JA; Dong Y; Ronning DR; Vennerstrom JL; Sanderson SD; Vetro JA
    ACS Infect Dis; 2020 May; 6(5):1169-1181. PubMed ID: 32233506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B
    Charest-Morin X; Bachelard H; Jean M; Marceau F
    PeerJ; 2017; 5():e2911. PubMed ID: 28133580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats.
    Sullivan CJ; Teal TH; Luttrell IP; Tran KB; Peters MA; Wessells H
    Physiol Genomics; 2005 Oct; 23(2):192-205. PubMed ID: 16118269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response-selective C5a agonists: differential effects on neutropenia and hypotension in the rat.
    Short AJ; Paczkowski NJ; Vogen SM; Sanderson SD; Taylor SM
    Br J Pharmacol; 1999 Oct; 128(3):511-4. PubMed ID: 10516626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversibility of tachyphylaxis to C5A in guinea pig tissues, perfused human placental lobule, and umbilical artery.
    Taylor SM; Finch AM; Heron AE; Brown LC; Florin TH
    Inflammation; 1994 Dec; 18(6):645-57. PubMed ID: 7843807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of the antimicrobial activity of bacitracin USP from its renovascular effects.
    Drapeau G; Petitclerc E; Toulouse A; Marceau F
    Antimicrob Agents Chemother; 1992 May; 36(5):955-61. PubMed ID: 1510419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.
    Stimler-Gerard NP
    Complement; 1986; 3(3):137-51. PubMed ID: 3026723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for vascular tone regulation by resident or infiltrating leukocytes.
    Marceau F
    Biochem Pharmacol; 1996 Nov; 52(10):1481-8. PubMed ID: 8937461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contractile effect of the chemotactic factors f-Met-Leu-Phe and C5a on the human isolated umbilical artery. Role of cyclooxygenase products and tissue macrophages.
    Marceau F; deBlois D; Laplante C; Petitclerc E; Pelletier G; Grose JH; Hugli TE
    Circ Res; 1990 Nov; 67(5):1059-70. PubMed ID: 1699682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the C5a anaphylatoxin and its relationship to cyclo-oxygenase metabolites in rabbit vascular strips.
    Hugli TE; Marceau F
    Br J Pharmacol; 1985 Mar; 84(3):725-33. PubMed ID: 3921089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxant effect of chemotactic peptides on rabbit vascular strips: evidence for nitric oxide release from a nonendothelial source.
    Petitclerc E; Marceau F
    Blood Vessels; 1991; 28(6):452-63. PubMed ID: 1782401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contractile effect of anaphylatoxin C5a and of a mimetic peptide on the human umbilical artery: further evidence for leukocyte-dependent vasomotion.
    Fortin JP; Bouthillier J; St-Pierre SA; Marceau F
    J Cardiovasc Pharmacol; 2002 Dec; 40(6):815-21. PubMed ID: 12451314
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.